Rare Disease
New Pain Medicine Seeking FDA Approval
People with rare and chronic disease often suffer from long term pain. New ways to alleviate this pain are needed. According to a press release
Alkermes Launches Phase 3 Program for Investigational Narcolepsy Therapy Alixorexton
- April 7, 2026
Can We Fix This Broken Heart? – Part 2
A New Hope for Treatment-Resistant Multiple Myeloma: CellCentric Advances InoPd into Pivotal Clinical Testing
Gilead Ends Midstage HIV Study as FDA Clinical Hold Continues
LISTEN TO OUR PODCAST
THE LATEST FROM PATIENT WORTHY
Rare Disease
A Small Taste of Freedom in an Unfree World
“Do not go gentle into that good night. Rage, rage against the dying of the light.” –Dylan Thomas One may have thought, after six months
Obesity
Oral GLP-1 Candidate Aleniglipron Shows Robust Weight Loss and Favorable Tolerability in Phase 2 Program
In a recent press release, Structure Therapeutics has reported encouraging topline results from its Phase 2 ACCESS clinical program evaluating aleniglipron, an investigational once-daily oral
Leigh syndrome
New Hope for Leigh Syndrome
As reported on Inside Precision Medicine, scientists in Germany have made an exciting discovery that could help children with a very rare and serious illness
Lung Cancer
Regulatory Fast-Track Transforms Lung Cancer Treatment Timeline; Gene Therapy Withdrawal Signals Market Challenges
The biotechnology sector witnessed a striking demonstration of expedited drug development this week, with Boehringer Ingelheim receiving FDA approval for an innovative lung cancer therapy
Rheumatoid Arthritis
Elevara Advances Oral CDK4/6 Inhibitor into Mid-stage Rheumatoid Arthritis Trial
As reported by Pharma Times, Elevara Medicines has initiated a phase 2b clinical study evaluating ELV001, an investigational oral CDK4/6 inhibitor, in people with rheumatoid
Triple-negative breast cancer
Dark Sweet Cherries Against Breast Cancer
Pictured above: Giuliana Noratto, Ph.D., (left) and Lauren Stranahan, Ph.D., led research showing that compounds in dark sweet cherries may help slow the growth and
Breast Cancer
Japan Advances Targeted Breast Cancer Treatment: Daiichi Sankyo Seeks Approval for Innovative Therapy After Surgery
Daiichi Sankyo has taken a significant step toward expanding treatment options in Japan by submitting regulatory approval for Enhertu, an advanced cancer-fighting drug designed to
Asthma
FDA Clears First Independent Generic of GSK’s Flovent Asthma Inhaler
As reported by FiercePharma, the U.S. Food and Drug Administration has approved the first fully independent generic version of GlaxoSmithKline’s widely used asthma inhaler, Flovent,
Trimethylaminuria
My Journey, My Life, My Story, My Book – Carry’s Experiences with “Fish Odor Syndrome”
You can not see, hear, or touch my rare condition. I STINK! (LITERALLY) I wasn’t sure if I was going to tell my story. But
HIV/AIDS
Scientists Redesign HIV-Fighting Antibodies to Strike Faster: A New Engineering Breakthrough
Researchers have created a fundamentally new class of HIV-fighting molecules by combining two separate antiviral mechanisms into a single engineered protein. Early laboratory results, reported
Psoriatic Arthritis
Bimzelx Outperforms Skyrizi in Psoriatic Arthritis Trial, Though Commercial Impact Remains Unclear
As reported on BioPharmaDive, UCB has reported positive results from a head-to-head clinical trial showing that its anti-inflammatory biologic Bimzelx was more effective than AbbVie’s
Colorectal cancer
Skipping A Colonoscopy Almost Cost Me Everything
Editor’s Note: Patient Worthy is proud and honored to share Jennifer’s story with cystic fibrosis and colon cancer, originally published on the Cystic Fibrosis Research
Seizures
Momentum Builds Across Biotech Pipeline: Seizure Breakthrough, Cell Therapy Revival, and Obesity Medicine Gains
The biotechnology sector experienced significant positive developments this week, with Xenon Pharmaceuticals’ seizure medication achieving a decisive late-stage victory while regulatory pathways accelerated for several
Breast Cancer
GLP-1 Receptor Agonists and Breast Cancer: Promising Signals, Pressing Questions
As reported on Healio, glucagon-like peptide-1 (GLP-1) receptor agonists, best known for treating diabetes and obesity, are emerging as unexpected players in breast cancer care.
Triple-negative breast cancer
Study: Engineered Immune Cells and Targeted Treatments May Slow the Spread of Triple-Negative Breast Cancer
CAR T- cells are immune cells that are engineered in a laboratory to attack cancer. The therapy has worked as planned for certain blood cancers
BRCA-mutated Breast Cancer
Breakthrough DNA Repair Inhibitor Advances Rapidly Toward Clinic: Artios’ ART6043 Earns FDA Fast Track Status for Resistant Breast Cancer
Artios Pharma has achieved a significant milestone in cancer treatment development with the U.S. Food and Drug Administration’s granting of Fast Track designation to ART6043,
Multiple Myeloma
Bristol Myers Squibb Reports Positive Phase 3 Data for Mezigdomide-Based Oral Regimen in Relapsed or Refractory Multiple Myeloma
As reported on drugs.com, Bristol Myers Squibb (BMS) has announced encouraging interim results from the Phase 3 portion of the SUCCESSOR-2 clinical trial evaluating oral
FEATURED
UPCOMING EVENTS
SIGN UP FOR OUR NEWSLETTER
HIV unfolds as a dynamic interaction between a virus and the immune system, moving through distinct phases that reflect shifting control over the body's defense. Shortly after exposure, the virus establishes itself rapidly, spreading through immune tissues and embedding into key cells that normally coordinate protection. Over time, even as the body mounts a response, HIV adapts and persists, creating a prolonged period where outward health may appear stable while subtle immune damage accumulates beneath the surface. Understanding this progression highlights why early detection and continuous treatment are essential to preserving immune function and long term health. Click the link below to share your story today - bit.ly/3VuxFDV #hivawareness #hiveducation #KnowYourStatus #PatientWorthy
Sotos syndrome is a rare genetic condition that affects growth and development, often leading to physical overgrowth in childhood along with developmental differences. Because it’s rare, many families may spend time searching for answers before receiving a diagnosis.
Raising awareness helps bring more understanding to conditions like Sotos syndrome and the individuals and families navigating them every day. By learning about rare diseases, we can help create a more informed, supportive community.
#SotosSyndrome #SotosSyndromeAwareness #RareDiseaseOfTheWeek #RareDiseaseAwareness #PatientWorthy
A New Hope for Treatment-Resistant Multiple Myeloma: CellCentric Advances InoPd into Pivotal Clinical Testing bit.ly/4slMlDA Read now at PatientWorthy.com
#PatientWorthy #multiplemyeloma #rrmm #clinicaltrials
